BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 18181724)

  • 1. Probiotics: definition, sources, selection, and uses.
    Sanders ME
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S58-61; discussion S144-51. PubMed ID: 18181724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in the United States.
    Vanderhoof JA; Young R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S67-72; discussion S144-51. PubMed ID: 18181726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics--the friendly bacteria with market potential in global market.
    Khan SH; Ansari FA
    Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of consumer probiotics for the US market.
    Sanders ME
    Br J Nutr; 1998 Oct; 80(4):S213-8. PubMed ID: 9924287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial-host interactions: selecting the right probiotics and prebiotics for infants.
    Salminen S; Collado MC; Isolauri E; Gueimonde M
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():201-13; discussion 213-7, 251-7. PubMed ID: 19710524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influencing health through intestinal microbiota modulation and probiotics.
    Sinclair A; Salminen S
    Asia Pac J Clin Nutr; 2006; 15(4):556-7. PubMed ID: 17077075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Business considerations in the development of probiotics.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
    Mattia A; Merker R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure, health information and flavour-masking strategies for improving the sensory quality of probiotic juice.
    Luckow T; Sheehan V; Fitzgerald G; Delahunty C
    Appetite; 2006 Nov; 47(3):315-23. PubMed ID: 16857295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen-free probiotics.
    Mogna G; Strozzi GP; Mogna L
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S201-4. PubMed ID: 18685500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and therapeutic uses of probiotics: a review.
    Kopp-Hoolihan L
    J Am Diet Assoc; 2001 Feb; 101(2):229-38; quiz 239-41. PubMed ID: 11271697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics: facts and myths.
    Senok AC; Ismaeel AY; Botta GA
    Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe and efficacious probiotics: what are they?
    Reid G
    Trends Microbiol; 2006 Aug; 14(8):348-52. PubMed ID: 16809039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental assessment requirements for live biological drugs.
    Sutton A
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S112-4; discussion S144-51. PubMed ID: 18181713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science and technology for the mastership of probiotic applications in food products.
    Makinen K; Berger B; Bel-Rhlid R; Ananta E
    J Biotechnol; 2012 Dec; 162(4):356-65. PubMed ID: 22828164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.